|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 5/02 | |
| C07K 7/02 |
| (11) | Number of the document | 3327027 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17201829.3 |
| Date of filing the European patent application | 2012-11-07 | |
| (97) | Date of publication of the European application | 2018-05-30 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161561255 P | 2011-11-17 | US | |
| 201261676423 P | 2012-07-27 | US |
| (72) |
DOROSKI, Matthew David, US
MADERNA, Andreas, US
O`DONNELL, Christopher John, US
SUBRAMANYAM, Chakrapani, US
VETELINO, Beth Cooper, US
DUSHIN, Russell George, US
STROP, Pavel, US
GRAZIANI, Edmund, Idris, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF |
| CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF |